Royalty Pharma plc ( RPRX) - Stock Earnings
RPRX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
RPRX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 214.2 million USD | 622.0 million USD |
| 2026Q1 | 295.0 million USD | 630.6 million USD |
| 2026Q2 | 17.9 million USD | 674.1 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
RPRX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 1.1 billion USD | 2.4 billion USD |
| 2024 | 859.0 million USD | 2.3 billion USD |
| 2025 | 770.9 million USD | 2.4 billion USD |
| 2026 Est. | — | — |
RPRX
List: Challengers
Price: $56.93
Dividend Yield: 1.62%
Forward Dividend Yield: 1.65%
Payout Ratio: 56.00%
Dividend Per Share: 0.94 USD
Earnings Per Share: 1.90 USD
P/E Ratio: 30.51
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.0 million
Ebitda: -16.0 millionMarket Capitalization: 25.3 billion
Average Dividend Frequency: 4
Years Paying Dividends: 7
DGR3: 5.55%